Fri Jul 14 16:53:46 2006
J Margolis
Papers by Joel Margolis
and the papers citing them.
stopwords, and 2-character and smaller words are excluded, Word count: 13344, All words count: 19386
Grand TLCS: 8346, Grand TGCS: 85074| View: Overview | Sorted by number of publications (Pubs). |
Page 7 of 22: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1201 | HISTORICAL | 2 | 0 | 18
|
| 1202 | HOMOLOGOUS | 2 | 1 | 16
|
| 1203 | HORMONES | 2 | 2 | 22
|
| 1204 | HUMAN-IMMUNODEFICIENCY-VIRUS | 2 | 0 | 39
|
| 1205 | HUMAN-PLACENTA | 2 | 0 | 31
|
| 1206 | HUMANS | 2 | 0 | 48
|
| 1207 | HUMORAL | 2 | 0 | 5
|
| 1208 | HYBRID | 2 | 2 | 9
|
| 1209 | HYDROLASE | 2 | 0 | 6
|
| 1210 | HYDROLYSIS | 2 | 31 | 62
|
| 1211 | HYDROLYTICALLY | 2 | 3 | 4
|
| 1212 | HYDROXYLASE | 2 | 1 | 35
|
| 1213 | HYPERCOAGULABILITY | 2 | 0 | 126
|
| 1214 | HYPERSENSITIVITY | 2 | 1 | 82
|
| 1215 | HYPOCOTYL | 2 | 0 | 14
|
| 1216 | HYPOTHYROIDISM | 2 | 2 | 9
|
| 1217 | IDENTIFIED | 2 | 2 | 46
|
| 1218 | IDENTITY | 2 | 4 | 236
|
| 1219 | IMMUNODIFFUSION | 2 | 8 | 16
|
| 1220 | IMMUNOELECTROPHORESIS | 2 | 3 | 38
|
| 1221 | IMMUNOGLOBULIN-M | 2 | 1 | 20
|
| 1222 | IMMUNOSUPPRESSIVE | 2 | 0 | 203
|
| 1223 | INACTIVATOR | 2 | 33 | 300
|
| 1224 | INACTIVE | 2 | 1 | 30
|
| 1225 | INCIDENCE | 2 | 0 | 60
|
| 1226 | INCORPORATION | 2 | 1 | 22
|
| 1227 | INDICATORS | 2 | 3 | 186
|
| 1228 | INFLUENCES | 2 | 3 | 19
|
| 1229 | INFUSIONS | 2 | 3 | 13
|
| 1230 | INGESTION | 2 | 2 | 33
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1231 | INITIAL | 2 | 56 | 107
|
| 1232 | INITIALE | 2 | 29 | 36
|
| 1233 | INITIATING | 2 | 7 | 82
|
| 1234 | INSULIN | 2 | 0 | 2
|
| 1235 | INTELLECTUAL | 2 | 0 | 35
|
| 1236 | INTERFACE | 2 | 1 | 38
|
| 1237 | INTERMEDIATE-PURITY | 2 | 14 | 14
|
| 1238 | INTERMEDIATES | 2 | 5 | 18
|
| 1239 | INTERRELATIONS | 2 | 30 | 36
|
| 1240 | INTERRELATIONSHIP | 2 | 162 | 182
|
| 1241 | INTESTINE | 2 | 0 | 112
|
| 1242 | INTRA-VASCULAR | 2 | 0 | 26
|
| 1243 | INTRACELLULAR | 2 | 4 | 59
|
| 1244 | INTRON | 2 | 2 | 143
|
| 1245 | INVOLVING | 2 | 4 | 30
|
| 1246 | ISOCITRATE | 2 | 2 | 57
|
| 1247 | ISOLATES | 2 | 1 | 287
|
| 1248 | J-CHAIN | 2 | 0 | 7
|
| 1249 | K-OXYTOCA | 2 | 0 | 32
|
| 1250 | KAOLIN-ACTIVATED | 2 | 31 | 126
|
| 1251 | KININASE | 2 | 7 | 35
|
| 1252 | KININE | 2 | 6 | 24
|
| 1253 | L-THREONINE | 2 | 1 | 3
|
| 1254 | LABELING | 2 | 0 | 211
|
| 1255 | LEAF | 2 | 0 | 63
|
| 1256 | LEGUMIN-LIKE | 2 | 1 | 31
|
| 1257 | LES | 2 | 13 | 28
|
| 1258 | LETHAL | 2 | 3 | 7
|
| 1259 | LEUCINE | 2 | 1 | 55
|
| 1260 | LEUKEMIA-VIRUS | 2 | 1 | 17
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1261 | LEUKOCYTE | 2 | 0 | 13
|
| 1262 | LEVEL | 2 | 1 | 16
|
| 1263 | LIGHT | 2 | 3 | 52
|
| 1264 | LIMIT | 2 | 1 | 13
|
| 1265 | LIPOLYTIC | 2 | 0 | 65
|
| 1266 | LOADING | 2 | 1 | 46
|
| 1267 | LOCALIZATION | 2 | 0 | 5
|
| 1268 | LONG | 2 | 3 | 16
|
| 1269 | LONG-CHAIN | 2 | 24 | 105
|
| 1270 | LOWERING | 2 | 4 | 49
|
| 1271 | LUNG | 2 | 9 | 64
|
| 1272 | LUNGS | 2 | 0 | 346
|
| 1273 | LUPUS-ERYTHEMATOSUS | 2 | 1 | 15
|
| 1274 | LYASE | 2 | 0 | 43
|
| 1275 | LYMPHOCYTE | 2 | 5 | 32
|
| 1276 | LYS | 2 | 1 | 32
|
| 1277 | MACROMOLECULAR | 2 | 2 | 118
|
| 1278 | MACROMOLECULES | 2 | 2 | 26
|
| 1279 | MAMMARY-GLAND | 2 | 0 | 22
|
| 1280 | MANIFESTATION | 2 | 2 | 7
|
| 1281 | MAPPING | 2 | 0 | 70
|
| 1282 | MATERIAL | 2 | 11 | 50
|
| 1283 | MATERIALS | 2 | 1 | 37
|
| 1284 | MATRICES | 2 | 2 | 7
|
| 1285 | MEASURING | 2 | 0 | 40
|
| 1286 | MELLITUS | 2 | 6 | 27
|
| 1287 | MEMBRANE-BOUND | 2 | 1 | 53
|
| 1288 | METABOLIC | 2 | 0 | 13
|
| 1289 | METHODIK | 2 | 6 | 36
|
| 1290 | METHODOLOGICAL | 2 | 9 | 98
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1291 | METHODOLOGIES | 2 | 0 | 7
|
| 1292 | METHYL | 2 | 29 | 66
|
| 1293 | MICRO | 2 | 7 | 22
|
| 1294 | MICROELECTROPHORETIC | 2 | 2 | 25
|
| 1295 | MICROSCALE | 2 | 3 | 12
|
| 1296 | MICROTUBULE | 2 | 1 | 52
|
| 1297 | MILD | 2 | 9 | 132
|
| 1298 | MILDLY | 2 | 11 | 45
|
| 1299 | MIT | 2 | 1 | 12
|
| 1300 | MITE | 2 | 1 | 104
|
| 1301 | MIXED | 2 | 0 | 4
|
| 1302 | MOBILIZATION | 2 | 15 | 136
|
| 1303 | MODELING | 2 | 0 | 12
|
| 1304 | MODELS | 2 | 1 | 20
|
| 1305 | MODERN | 2 | 2 | 26
|
| 1306 | MODIFICATION | 2 | 0 | 43
|
| 1307 | MODULATION | 2 | 0 | 5
|
| 1308 | MOLECULAR-CLONING | 2 | 0 | 52
|
| 1309 | MOLECULES | 2 | 3 | 42
|
| 1310 | MOLLUSCA | 2 | 4 | 13
|
| 1311 | MONKEY | 2 | 0 | 14
|
| 1312 | MONOMERIC | 2 | 1 | 30
|
| 1313 | MONOMERS | 2 | 2 | 8
|
| 1314 | MONOOXYGENASE | 2 | 1 | 189
|
| 1315 | MONOSODIUM | 2 | 0 | 106
|
| 1316 | MORTALITY | 2 | 0 | 120
|
| 1317 | MULTIFUNCTIONAL | 2 | 39 | 96
|
| 1318 | MURINE | 2 | 0 | 21
|
| 1319 | MYCOBACTERIUM | 2 | 2 | 34
|
| 1320 | MYELOMA | 2 | 0 | 12
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1321 | MYOCARDIAL-INFARCTION | 2 | 0 | 0
|
| 1322 | NATURALLY | 2 | 1 | 30
|
| 1323 | NEGATIVELY | 2 | 5 | 72
|
| 1324 | NERVE | 2 | 0 | 85
|
| 1325 | NETWORKS | 2 | 0 | 49
|
| 1326 | NEUROPATHY | 2 | 0 | 24
|
| 1327 | NEUTRAL | 2 | 1 | 85
|
| 1328 | NITRATE | 2 | 1 | 31
|
| 1329 | NORWAY | 2 | 2 | 87
|
| 1330 | NOUVELLES | 2 | 14 | 35
|
| 1331 | NUCLEOCYTOPLASMIC | 2 | 3 | 7
|
| 1332 | NUMBER | 2 | 0 | 5
|
| 1333 | NUTRITIONAL | 2 | 1 | 71
|
| 1334 | OBESE | 2 | 1 | 11
|
| 1335 | ONE | 2 | 3 | 24
|
| 1336 | ONE-STEP | 2 | 1 | 5
|
| 1337 | ORAL-CONTRACEPTIVES | 2 | 1 | 29
|
| 1338 | ORGANIC | 2 | 0 | 3
|
| 1339 | ORGANIZATION | 2 | 3 | 145
|
| 1340 | OVERLAPPING | 2 | 4 | 20
|
| 1341 | OXIDE | 2 | 0 | 76
|
| 1342 | PAF | 2 | 1 | 15
|
| 1343 | PAGE-TECHNIQUES | 2 | 2 | 15
|
| 1344 | PANCREATIC | 2 | 11 | 304
|
| 1345 | PANULIRUS-LONGIPES | 2 | 1 | 67
|
| 1346 | PARASITIZED | 2 | 0 | 35
|
| 1347 | PARTICLE | 2 | 3 | 14
|
| 1348 | PARTICLES | 2 | 0 | 26
|
| 1349 | PARTICULATE | 2 | 4 | 80
|
| 1350 | PAST | 2 | 0 | 7
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1351 | PATHOGENIC | 2 | 2 | 9
|
| 1352 | PATHOLOGIC | 2 | 12 | 110
|
| 1353 | PATHOLOGICAL | 2 | 34 | 82
|
| 1354 | PATHWAY | 2 | 2 | 24
|
| 1355 | PEANUT | 2 | 1 | 14
|
| 1356 | PEPSIN | 2 | 2 | 8
|
| 1357 | PEPTIDE | 2 | 2 | 662
|
| 1358 | PERFUSED | 2 | 1 | 90
|
| 1359 | PERIOD | 2 | 0 | 38
|
| 1360 | PH-BIASED | 2 | 4 | 14
|
| 1361 | PH-DEPENDENT | 2 | 4 | 67
|
| 1362 | PHAGOCYTOSIS | 2 | 0 | 55
|
| 1363 | PHARMACOLOGIC | 2 | 11 | 318
|
| 1364 | PHASEOLUS-VULGARIS | 2 | 0 | 8
|
| 1365 | PHASES | 2 | 64 | 313
|
| 1366 | PHOSPHATASE | 2 | 0 | 53
|
| 1367 | PHOSPHATASES | 2 | 0 | 46
|
| 1368 | PHOSPHATE | 2 | 0 | 43
|
| 1369 | PHOSPHOLIPID | 2 | 1 | 2
|
| 1370 | PIGS | 2 | 0 | 0
|
| 1371 | PLACENTA | 2 | 0 | 12
|
| 1372 | PLASMA-LEVELS | 2 | 0 | 9
|
| 1373 | PLASMA-PROTEIN | 2 | 0 | 22
|
| 1374 | PLASMA-VOLUME | 2 | 1 | 1
|
| 1375 | PLASMAKININE | 2 | 5 | 42
|
| 1376 | PLASMATIC | 2 | 0 | 8
|
| 1377 | PLASMIC | 2 | 6 | 189
|
| 1378 | POLICY | 2 | 27 | 656
|
| 1379 | POLY | 2 | 0 | 23
|
| 1380 | POLYACRYLAMIDES | 2 | 0 | 59
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1381 | POLYCHAETA | 2 | 0 | 17
|
| 1382 | POLYMERIZED | 2 | 4 | 20
|
| 1383 | POLYSACCHARIDE | 2 | 1 | 21
|
| 1384 | POLYSTYRENE | 2 | 3 | 9
|
| 1385 | POPULATIONS | 2 | 0 | 3
|
| 1386 | PORE-GRADIENT | 2 | 0 | 5
|
| 1387 | PORE-LIMIT | 2 | 68 | 133
|
| 1388 | POSITIVE | 2 | 4 | 37
|
| 1389 | POSTMENOPAUSAL | 2 | 0 | 38
|
| 1390 | POTENTIATED | 2 | 0 | 9
|
| 1391 | POTENTIATION | 2 | 10 | 48
|
| 1392 | PRE-KALLIKREIN | 2 | 14 | 29
|
| 1393 | PRECURSOR | 2 | 1 | 32
|
| 1394 | PREGNANT | 2 | 3 | 24
|
| 1395 | PROBLEM | 2 | 1 | 75
|
| 1396 | PROFILES | 2 | 1 | 283
|
| 1397 | PROGESTIN | 2 | 0 | 38
|
| 1398 | PROMOTING | 2 | 3 | 5
|
| 1399 | PROTEIN-PURIFICATION | 2 | 1 | 32
|
| 1400 | PROTEINASE-INHIBITOR | 2 | 4 | 25
|
Page 7 of 22: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21